National Guideline Clearinghouse | Search Results: CAPECITABINE NGC

National Guideline Clearinghouse | Search Results

October 14, 2013

'capecitabine'
Run an advanced search on this term

'' (Clear)

and '' (Clear)

Search Within Search within: Go

Sort results by: Relevance (what's this?) Publication date

Filter results by: All Years2013201220112010200920082007200620052004200320022000199919981997

1-18 of 18
1. Capecitabine for the treatment of advanced gastric cancer. 2010 Jul. NGC:008063 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
2. Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer. 2012 Aug. NGC:009311 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
3. Systemic therapy for advanced gastric cancer. 2010 Dec 16. NGC:008091 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
4. Colorectal cancer. The diagnosis and management of colorectal cancer. 2005 Aug (revised 2011 Nov). NGC:009033 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
5. The continued use of trastuzumab beyond disease progression in patients with metastatic breast cancer. 2009 Aug 17. NGC:007691 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
6. Colon cancer. 2008 Sep 23. NGC:006928 Comprehensive Cancer Centre the Netherlands - Disease Specific Society. View all guidelines by the developer(s) Compare Selected
7. The use of bevacizumab in metastatic breast cancer. 2009 Apr 17. NGC:007694 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
8. Advanced breast cancer. Diagnosis and treatment. 2003 May (revised 2009 Feb). NGC:007179 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
9. Diagnosis and management of colorectal cancer. A national clinical guideline. 2003 Mar (revised 2011 Dec). NGC:008894 Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
10. Practice parameters for the management of colon cancer. 2004 Aug (revised 2012 Aug). NGC:009295 American Society of Colon and Rectal Surgeons - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
11. ACR Appropriateness Criteria® resectable rectal cancer. 1998 (revised 2012). NGC:009218 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
12. ACR Appropriateness Criteria® rectal cancer—metastatic disease at presentation. 2007 (revised 2010). NGC:007949 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
13. Rectal cancer. 2008 Oct 14. NGC:006929 Comprehensive Cancer Centre the Netherlands - Disease Specific Society. View all guidelines by the developer(s) Compare Selected
14. Eribulin for the treatment of locally advanced or metastatic breast cancer. 2012 Apr. NGC:009074 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
15. Adjuvant systemic chemotherapy for stage II and III colon cancer following complete resection: guideline recommendations. 1997 Aug 25 (revised 2008 Apr 17). NGC:006528 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
16. Preoperative or postoperative therapy for the management of patients with stage II or III rectal cancer: guideline recommendations. 1998 Sep 5 (revised 2008 Jul 15). NGC:006706 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
17. Guideline for classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. 2010 Aug 11. NGC:008499 Pediatric Oncology Group of Ontario - Professional Association. View all guidelines by the developer(s) Compare Selected
18. ACR Appropriateness Criteria® follow-up and retreatment of brain metastases. 1999 (revised 2011). NGC:008878 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
1-18 of 18